Noy, Ariela

Publications

Sort by

Co-Author Network

selected publications

Burkitt Lymphoma - Subtypes, Pathogenesis, and Treatment Strategies. Clinical lymphoma, myeloma & leukemia. 2020 Academic Article GET IT
Times cited: 2
HIV-associated Burkitt lymphoma. The Lancet. Haematology. 2020 Review GET IT
Times cited: 29
Challenges of HIV Lymphoma Clinical Trials in Africa: Lessons From the AIDS Malignancy Consortium 068 Study. JCO global oncology. 2020 Academic Article GET IT
Times cited: 2
Multicenter Study of Risk-Adapted Therapy With Dose-Adjusted EPOCH-R in Adults With Untreated Burkitt Lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2020 Academic Article GET IT
Times cited: 57
HIV Lymphoma and Burkitts Lymphoma. Cancer journal (Sudbury, Mass.). 2020 Review GET IT
Times cited: 5
Optimizing treatment of HIV-associated lymphoma. Blood. 2019 Review GET IT
Times cited: 39
Phase 2 Study of Iodine-131 Tositumomab Plus Chemotherapy in Patients With Previously Untreated Mantle-Cell Lymphoma. Clinical lymphoma, myeloma & leukemia. 2019 Academic Article GET IT
Times cited: 1
Genome-wide discovery of somatic coding and noncoding mutations in pediatric endemic and sporadic Burkitt lymphoma. Blood. 2019 Academic Article GET IT
Times cited: 119
Integrated DNA/RNA targeted genomic profiling of diffuse large B-cell lymphoma using a clinical assay. Blood cancer journal. 2018 Academic Article GET IT
Times cited: 22
Brentuximab vedotin with AVD shows safety, in the absence of strong CYP3A4 inhibitors, in newly diagnosed HIV-associated Hodgkin lymphoma. AIDS (London, England). 2018 Academic Article GET IT
Times cited: 18
Safety and Preliminary Efficacy of Vorinostat With R-EPOCH in High-risk HIV-associated Non-Hodgkin's Lymphoma (AMC-075). Clinical lymphoma, myeloma & leukemia. 2018 Academic Article GET IT
Times cited: 10
A phase 1 study of ibrutinib in combination with R-ICE in patients with relapsed or primary refractory DLBCL. Blood. 2018 Academic Article GET IT
Times cited: 47
Combination antiretroviral therapy accelerates immune recovery in patients with HIV-related lymphoma treated with EPOCH: a comparison within one prospective trial AMC034. Leukemia & lymphoma. 2017 Academic Article GET IT
Times cited: 11
Modernizing Clinical Trial Eligibility Criteria: Recommendations of the American Society of Clinical Oncology-Friends of Cancer Research HIV Working Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2017 Academic Article GET IT
Times cited: 90
Ibrutinib Unmasks Critical Role of Bruton Tyrosine Kinase in Primary CNS Lymphoma. Cancer discovery. 2017 Academic Article GET IT
Times cited: 243
HIV multicentric Castleman: rituximab sans maintenance. Blood. 2017 Comment GET IT
Times cited: 1
Targeting Bruton tyrosine kinase with ibrutinib in relapsed/refractory marginal zone lymphoma. Blood. 2017 Academic Article GET IT
Times cited: 211
Risk of Cancer among Commercially Insured HIV-Infected Adults on Antiretroviral Therapy. Journal of cancer epidemiology. 2016 Academic Article GET IT
Times cited: 78
Brentuximab vedotin and AVD followed by involved-site radiotherapy in early stage, unfavorable risk Hodgkin lymphoma. Blood. 2016 Academic Article GET IT
Times cited: 54
Feasibility of interim positron emission tomography (PET)-adapted therapy in HIV-positive patients with advanced Hodgkin lymphoma (HL): a sub-analysis of SWOG S0816 Phase 2 trial. Leukemia & lymphoma. 2016 Letter GET IT
Times cited: 16
Autologous hematopoietic cell transplantation for HIV-related lymphoma: results of the BMT CTN 0803/AMC 071 trial. Blood. 2016 Academic Article GET IT
Times cited: 65
US Intergroup Trial of Response-Adapted Therapy for Stage III to IV Hodgkin Lymphoma Using Early Interim Fluorodeoxyglucose-Positron Emission Tomography Imaging: Southwest Oncology Group S0816. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2016 Academic Article GET IT
Times cited: 201
Central nervous system involvement in AIDS-related lymphomas. British journal of haematology. 2016 Academic Article GET IT
Times cited: 14
Cancer and Fertility Program Improves Patient Satisfaction With Information Received. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2016 Academic Article GET IT
Times cited: 59
Prospective Study of 3'-Deoxy-3'-18F-Fluorothymidine PET for Early Interim Response Assessment in Advanced-Stage B-Cell Lymphoma. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2015 Academic Article GET IT
Times cited: 33
Impact of surgery, radiation and systemic therapy on the outcomes of patients with dendritic cell and histiocytic sarcomas. European journal of cancer (Oxford, England : 1990). 2015 Academic Article GET IT
Times cited: 69
AMC 048: modified CODOX-M/IVAC-rituximab is safe and effective for HIV-associated Burkitt lymphoma. Blood. 2015 Academic Article GET IT
Times cited: 66
Long-term outcomes and patterns of relapse of early-stage extranodal marginal zone lymphoma treated with radiation therapy with curative intent. International journal of radiation oncology, biology, physics. 2015 Academic Article GET IT
Times cited: 50
PET-adapted sequential salvage therapy with brentuximab vedotin followed by augmented ifosamide, carboplatin, and etoposide for patients with relapsed and refractory Hodgkin's lymphoma: a non-randomised, open-label, single-centre, phase 2 study. The Lancet. Oncology. 2015 Academic Article GET IT
Times cited: 201
Changes in the influence of lymphoma- and HIV-specific factors on outcomes in AIDS-related non-Hodgkin lymphoma. Annals of oncology : official journal of the European Society for Medical Oncology. 2015 Review GET IT
Times cited: 66
Phase I/II trial of vorinostat with rituximab, cyclophosphamide, etoposide and prednisone as palliative treatment for elderly patients with relapsed or refractory diffuse large B-cell lymphoma not eligible for autologous stem cell transplantation. British journal of haematology. 2014 Academic Article GET IT
Times cited: 29
A new prognostic score for AIDS-related lymphomas in the rituximab-era. Haematologica. 2014 Review GET IT
Times cited: 35
Phase II trial of imatinib in AIDS-associated Kaposi's sarcoma: AIDS Malignancy Consortium Protocol 042. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2013 Academic Article GET IT
Times cited: 75
Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patients. Blood. 2013 Review GET IT
Times cited: 137
Successful management of gastric perforation in stage IV diffuse large B-cell lymphoma with chemoradiation therapy, percutaneous endoscopy gastrostomy for gastric drainage, and percutaneous endoscopy jejunostomy for nutrition. 2012 GET IT
Times cited: 2
Phase II study of bendamustine in relapsed and refractory Hodgkin lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2012 Academic Article GET IT
Times cited: 163
Randomized controlled trial of a video decision support tool for cardiopulmonary resuscitation decision making in advanced cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2012 Academic Article GET IT
Times cited: 131
Pegylated liposomal doxorubicin, rituximab, cyclophosphamide, vincristine, and prednisone in AIDS-related lymphoma: AIDS Malignancy Consortium Study 047. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2012 Academic Article GET IT
Times cited: 21
Outcome of patients with relapsed/refractory acquired immune deficiency syndrome-related lymphoma diagnosed 1999-2008 and treated with curative intent in the AIDS Malignancy Consortium. Leukemia & lymphoma. 2012 Academic Article GET IT
Times cited: 20
Selective CDK4/6 inhibition with tumor responses by PD0332991 in patients with mantle cell lymphoma. Blood. 2012 Academic Article GET IT
Times cited: 256
Augmenting advance care planning in poor prognosis cancer with a video decision aid: a preintervention-postintervention study. Cancer. 2012 Academic Article GET IT
Times cited: 65
Normalization of pre-ASCT, FDG-PET imaging with second-line, non-cross-resistant, chemotherapy programs improves event-free survival in patients with Hodgkin lymphoma. Blood. 2011 Academic Article GET IT
Times cited: 226
Pooled analysis of AIDS malignancy consortium trials evaluating rituximab plus CHOP or infusional EPOCH chemotherapy in HIV-associated non-Hodgkin lymphoma. Cancer. 2011 Academic Article GET IT
Times cited: 66
MCD & HHV-8 viral load. Blood. 2011 Comment GET IT
Expert second-opinion pathology review of lymphoma in the era of the World Health Organization classification. Annals of oncology : official journal of the European Society for Medical Oncology. 2011 Academic Article GET IT
Times cited: 37
Phase I trial of weekly and twice-weekly bortezomib with rituximab, cyclophosphamide, and prednisone in relapsed or refractory non-Hodgkin lymphoma. Clinical cancer research : an official journal of the American Association for Cancer Research. 2011 Academic Article GET IT
Times cited: 25
Controversies in the treatment of Burkitt lymphoma in AIDS. Current opinion in oncology. 2010 Review GET IT
Times cited: 18
Spectrum of HIV lymphoma 2009. Current opinion in hematology. 2010 Review GET IT
Times cited: 18
Risk-adapted dose-dense immunochemotherapy determined by interim FDG-PET in Advanced-stage diffuse large B-Cell lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2010 Academic Article GET IT
Times cited: 269
High-dose chemo-radiotherapy for relapsed or refractory Hodgkin lymphoma and the significance of pre-transplant functional imaging. British journal of haematology. 2010 Academic Article GET IT
Times cited: 80
Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma. Blood. 2009 Academic Article GET IT
Times cited: 199
Fourth complete remission with immunosuppression withdrawal and irinotecan after both autologous and allogeneic transplants for diffuse large B cell lymphoma. Leukemia & lymphoma. 2009 Letter GET IT
Times cited: 3
Telomeres: the long and short of developing non-Hodgkin lymphoma. Clinical cancer research : an official journal of the American Association for Cancer Research. 2009 Comment GET IT
Times cited: 9
Pertussis immunity and response to tetanus-reduced diphtheria-reduced pertussis vaccine (Tdap) after autologous peripheral blood stem cell transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2009 Academic Article GET IT
Times cited: 33
Stanford V program for locally extensive and advanced Hodgkin lymphoma: the Memorial Sloan-Kettering Cancer Center experience. Annals of oncology : official journal of the European Society for Medical Oncology. 2009 Academic Article GET IT
Times cited: 27
Immunophenotypic analysis of AIDS-related diffuse large B-cell lymphoma and clinical implications in patients from AIDS Malignancies Consortium clinical trials 010 and 034. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2009 Academic Article GET IT
Times cited: 77
Effects of chemotherapy in AIDS-associated non-Hodgkin's lymphoma on Kaposi's sarcoma herpesvirus DNA in blood. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2009 Academic Article GET IT
Times cited: 23
Human T cell leukemia virus reactivation with progression of adult T-cell leukemia-lymphoma. PloS one. 2009 Academic Article GET IT
Times cited: 41
The majority of transformed lymphomas have high standardized uptake values (SUVs) on positron emission tomography (PET) scanning similar to diffuse large B-cell lymphoma (DLBCL). Annals of oncology : official journal of the European Society for Medical Oncology. 2009 Academic Article GET IT
Times cited: 126
Sequential therapy with fludarabine, high-dose cyclophosphamide, and rituximab in previously untreated patients with chronic lymphocytic leukemia produces high-quality responses: molecular remissions predict for durable complete responses. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2008 Academic Article GET IT
Times cited: 62
Pralatrexate, a novel class of antifol with high affinity for the reduced folate carrier-type 1, produces marked complete and durable remissions in a diversity of chemotherapy refractory cases of T-cell lymphoma. British journal of haematology. 2007 Academic Article GET IT
Times cited: 79
Infectious disease associations in advanced stage, indolent lymphoma (follicular and nonfollicular): developing a lymphoma prevention strategy. Annals of oncology : official journal of the European Society for Medical Oncology. 2007 Academic Article GET IT
Times cited: 5
Update on HIV lymphoma. Current oncology reports. 2007 Review GET IT
Times cited: 8
Successful treatment of marginal zone lymphoma with splenectomy alone despite HIV infection. AIDS (London, England). 2007 Letter GET IT
Times cited: 4
Fatal hepatorenal failure and thrombocytopenia with SU5416, a vascular endothelial growth factor Flk-1 receptor inhibitor, in AIDS-Kaposi's sarcoma. AIDS (London, England). 2007 Letter GET IT
Times cited: 3
Possible role of edotecarin, a novel topoisomerase I inhibitor, in therapy-related myelodysplastic syndrome. Leukemia & lymphoma. 2007 Letter GET IT
Times cited: 1
Update in HIV lymphoma. Current opinion in oncology. 2006 Review GET IT
Times cited: 21
Developing a cancer-specific geriatric assessment: a feasibility study. Cancer. 2005 Academic Article GET IT
Times cited: 505
Primary mediastinal large B-cell lymphoma: optimal therapy and prognostic factor analysis in 141 consecutive patients treated at Memorial Sloan Kettering from 1980 to 1999. British journal of haematology. 2005 Academic Article GET IT
Times cited: 109
Gastric mucosa-associated lymphoid tissue lymphoma detected by clonotypic polymerase chain reaction despite continuous pathologic remission induced by involved-field radiotherapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005 Academic Article GET IT
Times cited: 14
Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin's lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005 Academic Article GET IT
Times cited: 426
R-CHOP-14 in patients with diffuse large B-cell lymphoma: feasibility and preliminary efficacy. Leukemia & lymphoma. 2005 Academic Article GET IT
Times cited: 39
Angiogenesis inhibitor IM862 is ineffective against AIDS-Kaposi's sarcoma in a phase III trial, but demonstrates sustained, potent effect of highly active antiretroviral therapy: from the AIDS Malignancy Consortium and IM862 Study Team. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2004 Academic Article GET IT
Times cited: 39
CD20-negative large-cell lymphoma with plasmablastic features: a clinically heterogenous spectrum in both HIV-positive and -negative patients. Annals of oncology : official journal of the European Society for Medical Oncology. 2004 Academic Article GET IT
Times cited: 171
Update in HIV-associated lymphoma. Current opinion in oncology. 2004 Review GET IT
Times cited: 9
Results of a prospective randomized clinical trial of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) followed by radiation therapy (RT) versus ABVD alone for stages I, II, and IIIA nonbulky Hodgkin disease. Blood. 2004 Academic Article GET IT
Times cited: 232
Adverse prognostic significance of CD20 positive Reed-Sternberg cells in classical Hodgkin's disease. British journal of haematology. 2004 Academic Article GET IT
Times cited: 61
Rituximab and ICE as second-line therapy before autologous stem cell transplantation for relapsed or primary refractory diffuse large B-cell lymphoma. Blood. 2004 Academic Article GET IT
Times cited: 349
Intensive chemotherapy with cyclophosphamide, doxorubicin, high-dose methotrexate/ifosfamide, etoposide, and high-dose cytarabine (CODOX-M/IVAC) for human immunodeficiency virus-associated Burkitt lymphoma. Cancer. 2003 Academic Article GET IT
Times cited: 134
Update in Kaposi sarcoma. Current opinion in oncology. 2003 Review GET IT
Times cited: 8
Age-adjusted International Prognostic Index predicts autologous stem cell transplantation outcome for patients with relapsed or primary refractory diffuse large B-cell lymphoma. Blood. 2003 Academic Article GET IT
Times cited: 220
Rituximab for aggressive non-Hodgkin's lymphomas relapsing after or refractory to autologous stem cell transplantation. Cancer journal (Sudbury, Mass.). 2002 Academic Article GET IT
Times cited: 22
Clonotypic polymerase chain reaction confirms minimal residual disease in CLL nodular PR: results from a sequential treatment CLL protocol. Blood. 2001 Academic Article GET IT
Times cited: 26
A 2-step comprehensive high-dose chemoradiotherapy second-line program for relapsed and refractory Hodgkin disease: analysis by intent to treat and development of a prognostic model. Blood. 2001 Academic Article GET IT
Times cited: 374
Cyclophosphamide/fludarabine (CF) is active in the treatment of mantle cell lymphoma. Leukemia & lymphoma. 2001 Academic Article GET IT
Times cited: 64
Consolidation therapy with high-dose cyclophosphamide improves the quality of response in patients with chronic lymphocytic leukemia treated with fludarabine as induction therapy. Leukemia. 2000 Academic Article GET IT
Times cited: 40
Ifosfamide, carboplatin, and etoposide: a highly effective cytoreduction and peripheral-blood progenitor-cell mobilization regimen for transplant-eligible patients with non-Hodgkin's lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1999 Academic Article GET IT
Times cited: 275
Del (7)(q32) is associated with a subset of small lymphocytic lymphoma with plasmacytoid features. Blood. 1995 Academic Article GET IT
Times cited: 36
Clinical review 63: Diabetes and pancreatic cancer: clues to the early diagnosis of pancreatic malignancy. The Journal of clinical endocrinology and metabolism. 1994 Review GET IT
Times cited: 82

more ...

less ...

Background

education and training

M.D., University of Pennsylvania School of Medicine 1990
B.A., Princeton University 1986

Contact

full name

Ariela Noy

primary email

arn2006@med.cornell.edu

VIVO Weill Cornell Medical College

Ariela Noy Professor of Clinical Medicine

Publications

selected publications

Background

education and training

Contact

full name

primary email

Phone

Publications

selected publications

Background

education and training

Contact

full name

primary email